New Millennium Group’s STAAR Surgical STAA Stock Holding History

New Millennium Group’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-109	Closed	-$8K	–	478
2022 Q3	$8K	Hold	109	–	–	0.01%	210
2022 Q2	$8K	Buy	+109	New	+$7.02K	0.01%	211

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EFM

E Fund Management Guangzhou, China $3.37B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

New Millennium Group's STAA Position: Q4 2022 in Review

New Millennium Group sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 109 shares — an estimated $8K sold.

New Millennium Group first reported a position in STAA in Q2 2022 and held it in 2 quarters. The position peaked at $8K in Q3 2022. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

New Millennium Group reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
New Millennium Group sold 109 STAAR Surgical shares in Q4 2022, an estimated $8K.
New Millennium Group first reported a position in STAAR Surgical in Q2 2022 and held it in 2 quarters.
New Millennium Group's STAAR Surgical position peaked at $8K in Q3 2022.
275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on New Millennium Group's 13F filing for Q4 2022, filed 7 Feb 2023.